About BLAB

Founded: n/a
Employees: n/a
CEO: Peter Shippen
WebsiteView website: britannia.life

Britannia Life Sciences Inc. engages in the product testing, safety assessment, and manufacturing services in the United Kingdom and internationally. It serves cosmetics, consumer packaged and household goods, and nutraceutical industries. The company is headquartered in Toronto, Canada.

Recent BLAB News & Updates

New Risk • Apr 10

New major risk - Market cap size

The company's market capitalization is less than US$10m. Market cap: CA$13.8m (US$9.98m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (185% accrual ratio). Revenue is less than US$1m (CA$158k revenue, or US$114k). Market cap is less than US$10m (CA$13.8m market cap, or US$9.98m).

Recent updates

No updates

Britannia Life Sciences Inc. Stock Price

BLAB Share Price Performance

BLAB Community Narratives

Trending Discussion

Recently Updated Narratives

Snowflake Analysis

Britannia Life Sciences Inc. Key Details

About BLAB

Recent BLAB News & Updates

New major risk - Market cap size

Third quarter 2026 earnings released: EPS: CA$0.067 (vs CA$0.002 loss in 3Q 2025)

Does Britannia Life Sciences (CSE:BLAB) Have A Healthy Balance Sheet?

Recent updates

Britannia Life Sciences Inc. Competitors

Northstar Clean Technologies

Caldwell Partners International

Ecolomondo

PlasCred Circular Innovations